For vasodilatory shock. Sold as Vasostrict, Vasopressin, Vasopressin In Sodium Chloride 0.9%. Every FDA application for this active ingredient: 4 branded and 11 generic.
As of Nov 15, 2026, FDA lists 15 applications for Vasopressin (sold as Vasostrict, Vasopressin, Vasopressin In Sodium Chloride 0.9%), first approved Apr 17, 2014, with 0 new uses approved and 0 published complete response letters.
| Vasopressin (J2598) | Part B | $1K | -99% | 15 |
| Vasopressin (J2599) | Part B | $0K | -100% | 0 |
| The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older AdultsDehydrated, Water-Electrolyte Imbalance, Malnutrition, Dehydration (Physiology) · Polytechnic University of Santarém | Not applicable | Recruiting | Oct 23, 2026 |
| Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face AttentionHealhty · University of Electronic Science and Technology of China | Not applicable | Recruiting | Sep 24, 2026 |
| Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineMigraine · Nordlandssykehuset HF | — | Enrolling by invitation | Sep 21, 2026 |
| Bedtime Device Restriction and Desmopressin in PMNE.Primary Monosymptomatic Nocturnal Enuresis · Al-Azhar University | Not applicable | Recruiting | Aug 20, 2026 |
| Terlipressin vs Placebo to Reduce Bleeding in Fibroid SurgeryUterine Fibroids (Leiomyoma), Uterine Myoma · Sevil Cankaya | Not applicable | Not yet recruiting | Aug 5, 2026 |
| Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region TumorsCraniopharyngiomas, Pituitary Macroadenoma · Zhaoyun Zhang | Phase 4 | Enrolling by invitation | Jul 17, 2026 |
| Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic ShockSeptic Shock and Use of Vasopressin · Assistance Publique - Hôpitaux de Paris | — | Not yet recruiting | Jul 13, 2026 |
| Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)Vasoplegic Shock, Cardiopulmonary Bypass · Methodist Healthcare System of San Antonio | Phase 4 | Not yet recruiting | Jun 26, 2026 |
| Apr 17, 2014 | VasostrictNDA 204485 · TYPE 7 | Ph Health | 14 | Marketed |
| Aug 3, 2020 | VasopressinNDA 212593 · New formulation or manufacturer | Am Regent | 0 | Marketed |
| Dec 15, 2021 | VasopressinANDA 211538 | Eagle Pharms | 0 | Discontinued |
| Jul 18, 2022 | VasopressinANDA 211857 | Amphastar Pharms Inc | 0 | Marketed |
| Aug 5, 2022 | VasopressinANDA 212944 | Amneal | 1 | Marketed |
| Aug 15, 2022 | VasopressinANDA 214314 | Eugia Pharma | 0 | Marketed |
| May 26, 2023 | VasopressinANDA 213206 | Fresenius Kabi USA | 0 | Marketed |
| Sep 29, 2023 | Vasopressin In Sodium Chloride 0.9%NDA 217569 · New formulation or manufacturer | Baxter Hlthcare Corp | 2 | Marketed |
| Dec 6, 2023 | VasopressinANDA 217987 | Cipla | 0 | Marketed |
| Feb 9, 2024 | Vasopressin, Vasopressin In Dextrose 5%ANDA 216963 | Gland | 0 | Marketed |
| May 8, 2024 | Vasopressin, Vasopressin In Dextrose 5%ANDA 213988 | Dr Reddys | 2 | Marketed |
| Jul 11, 2024 | Vasopressin In Sodium Chloride 0.9%NDA 217766 · New dosage form | Long Grove Pharms | 0 | Marketed |
| May 6, 2026 | VasopressinANDA 212068 | Sandoz | 0 | Marketed |
| May 6, 2026 | VasopressinANDA 212069 | Sandoz | 0 | Marketed |
| — | VasopressinANDA 212945 | Amneal Eu Ltd | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Eugia Pharma
Fresenius Kabi USA
Baxter Hlthcare Corp
Cipla
Sandoz